BDBM627011 N,1′,3′-Trimethyl-2-(2-(1-methyl-1H-imidazol-5-yl)quinolin-4-yl)-2′-oxo-2′,3′-dihydro-1′H-[1,5′-bibenzo[d]imidazole]-5-carboxamide::US11787802, Example 17

SMILES CNC(=O)c1ccc2n(c(nc2c1)-c1cc(nc2ccccc12)-c1cncn1C)-c1ccc2n(C)c(=O)n(C)c2c1

InChI Key InChIKey=MNHMCDLAVZABLZ-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 627011   

TargetDNA damage-binding protein 1/Protein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 627011BDBM627011(US11787802, Example 17 | N,1′,3′-Trime...)
Affinity DataKd:  42nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
US Patent